Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03964974 · ClinicalTrials.gov registry record · NA
Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis
A NA study of Cannabis Use and Insomnia Chronic, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 2
- Study locations
NCT03964974: Completed NA study of Cannabis Use and Insomnia Chronic, sponsored by University of Michigan.
NCT03964974 is a NA study of Cannabis Use and Insomnia Chronic that has completed, run by University of Michigan. The registered enrollment target is 57 participants, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03964974, a NA study of Cannabis Use and Insomnia Chronic, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 2
- Study locations
Study Summary
As medical cannabis use becomes more common in the United States, it is essential to understand the ways in which adults who use medical cannabis perceive the benefits of cannabis use and to identify effective strategies to help them cope with these problems. Emerging data indicate that insomnia and/or use of cannabis for sleep are very common in medical cannabis patients. The present study will adapt and gather pilot data on the impact of a Cognitive Behavioral Therapy for insomnia (CBTi-CB) intervention on sleep- and cannabis-related outcomes in adults who use medical cannabis.
Primary Outcome
The Insomnia Severity Index (ISI) is a brief self-report instrument measuring the patient's perception of both nocturnal and diurnal symptoms of insomnia. The ISI comprises seven items assessing the perceived severity of difficulties initiating sleep, staying asleep, and early morning awakenings, satisfaction with current sleep pattern, interference with daily functioning, noticeability of impairment attributed to the sleep problem, and degree of distress or concern caused by the sleep problem.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Hygiene Education (SHE)
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia in Cannabis Users (CBTi-CB)
Study Locations (2)
Michigan
- Bloom City Club - Ann Arbor
- Om of Medicine - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2021-07-13 |
| Phase | NA |
What the finished NCT03964974 record still lists
NCT03964974 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Cannabis Use appearing as the primary indexed condition, and to 2 interventions - of which Sleep Hygiene Education (SHE) is the first listed.
NCT03964974 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03964974 about?
NCT03964974 is a clinical study titled "Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis". As medical cannabis use becomes more common in the United States, it is essential to understand the ways in which adults who use medical cannabis perceive the benefits of cannabis use and to identify effective strategies to help them cope with these problems. Emerging data indicate that insomnia and...
What is the current status of trial NCT03964974?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2020-02-10. Estimated completion is 2021-07-13.
What conditions does trial NCT03964974 study?
This clinical trial studies the following conditions: Cannabis Use, Insomnia Chronic.
What interventions are being tested in trial NCT03964974?
The interventions under investigation include: Sleep Hygiene Education (SHE) (BEHAVIORAL), Cognitive Behavioral Therapy for Insomnia in Cannabis Users (CBTi-CB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03964974?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03964974 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03964974's enrollment target sits among peer trials
57 34th of 44 higher than 11 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
RECRUITING · NA
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Stress and Resilience
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI